Public Policy and Advocacy

Real change can only come from changing the system. Susan G. Komen is the non-partisan voice for more than 3.5 million breast cancer survivors and the people who love them. The mission of Komen advocates? Translate the Komen promise to end breast cancer forever into action at all levels of government.

Komen Advocates  help influence policy that:

  • Ensures access to breast health screening and diagnostics for all women
  • Maintains breast cancer research as a priority
  • Accelerates the process for delivering scientific discoveries to those who need them while maintaining patient safety

Through the power of our Advocates, Komen has helped on the Federal level to:

  • Preserve $197 million in federal funding and over $100 million in state funding for life-saving breast screening services
  • Increase Federal breast cancer research funding from $30 million to over $970 million in the last 30 years
  • Secure $37 billion for the National Institutes for Health overall

The six Komen affiliates in California team up and collectively work on public policy as the Komen California Collaborative Public Policy Committee (KCCPPC). Together, through advocacy, the KCCPPC has helped to:

  • Expand eligibility for life-saving screening services to individuals under 40 years of age who present symptoms or concern
  • Allow individuals to re-enroll in life-saving treatment programs in the case of a breast cancer recurrence
  • Secure out of pocket caps for oral (pill form) chemotherapy
  • Ensure individuals are notified of dense breast tissue to enable discuss with doctors of the most effective screening plans

To see a full list of recent legislative accomplishments in California, click here

Currently, Komen San Diego is working on two bills to increase access to breast cancer treatments in California:

 AB 1860

Success! On September 17, Governor Brown signed this Komen-sponsored bill to remove the sunset (expiration date) on an existing law that caps out-of-pocket costs for oral (pill form) chemotherapy. Without this win patients could have been required to pay a coinsurance that could have cost them thousands of dollars each month. This bill ensures patients won’t be forced to choose a less appropriate treatment option—or forgo drug therapy altogether—and are free to make treatment decisions with their physicians based on what is best for the patient.

SB 945 

SUCCESS! This year we worked on a bill that removed the treatment caps in the Breast and Cervical Cancer Treatment Program (BCCTP). Prior to July 2018, the BCCTP only provided treatment for breast and cervical cancer up to 18 and 24 months, respectively. Now individuals enrolled in this program can remain in treatment for the duration of their prescribed treatment plan! Read more here, SB 945 Fact Sheet.

While we have made important accomplishments in the fight to end breast cancer, there is still much to do and we can’t do it without your help. Please join the movement of breast cancer survivors and activists committed to making a difference!